Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies

Cell

Volumn 134, Issue 4, 2008, Pages 668-678

  Newton, Kim ^a   Matsumoto, Marissa L ^a   Wertz, Ingrid E ^a   Kirkpatrick, Donald S ^a   Lill, Jennie R ^a   Tan, Jenille ^a   Dugger, Debra ^a   Gordon, Nathaniel ^a   Sidhu, Sachdev S ^a   Fellouse, Frederic A ^a   Komuves, Laszlo ^a   French, Dorothy M ^a   Ferrando, Ronald E ^a   Lam, Cynthia ^a   Compaan, Deanne ^a   Yu, Christine ^a   Bosanac, Ivan ^a   Hymowitz, Sarah G ^a   Kelley, Robert F ^a   Dixit, Vishva M ^a  

^a GENENTECH INC   (United States)

Author keywords

CELLBIO; MOLIMMUNO; PROTEINS

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; LYSINE DERIVATIVE; PHOSPHOTRANSFERASE; POLYUBIQUITIN; PROTEASOME; PROTEIN DERIVATIVE; RIP1 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; CRYSTAL STRUCTURE; EMBRYO; ENZYME DEGRADATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTROSPECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 49549117842     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.07.039     Document Type: Article

References (29)

1. Bennett E.J., Shaler T.A., Woodman B., Ryu K.Y., Zaitseva T.S., Becker C.H., Bates G.P., Schulman H., and Kopito R.R. Global changes to the ubiquitin system in Huntington's disease. Nature 448 (2007) 704-708
2. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5 (2004) 1052-1060
3. Conze D.B., Wu C.J., Thomas J.A., Landstrom A., and Ashwell J.D. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation. Mol. Cell. Biol. 28 (2008) 3538-3547
4. Cook W.J., Jeffrey L.C., Carson M., Chen Z., and Pickart C.M. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J. Biol. Chem. 267 (1992) 16467-16471
5. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., and Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
6. Ea C.K., Deng L., Xia Z.P., Pineda G., and Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
7. Fellouse F.A., Esaki K., Birtalan S., Raptis D., Cancasci V.J., Koide A., Jhurani P., Vasser M., Wiesmann C., Kossiakoff A.A., et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J. Mol. Biol. 373 (2007) 924-940
8. Finley D., Sadis S., Monia B.P., Boucher P., Ecker D.J., Crooke S.T., and Chau V. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol. 14 (1994) 5501-5509
9. Hayden M.S., and Ghosh S. Shared principles in NF-κB signaling. Cell 132 (2008) 344-362
10. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
11. Kanakaraj P., Schafer P.H., Cavender D.E., Wu Y., Ngo K., Grealish P.F., Wadsworth S.A., Peterson P.A., Siekierka J.J., Harris C.A., and Fung-Leung W.P. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187 (1998) 2073-2079
12. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., Gygi S.P., and Goldberg A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282 (2007) 17375-17386
13. Kirkpatrick D.S., Hathaway N.A., Hanna J., Elsasser S., Rush J., Finley D., King R.W., and Gygi S.P. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 8 (2006) 700-710
14. Lee C.V., Liang W.C., Dennis M.S., Eigenbrot C., Sidhu S.S., and Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J. Mol. Biol. 340 (2004) 1073-1093
15. Lee T.H., Shank J., Cusson N., and Kelliher M.A. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279 (2004) 33185-33191
16. Legler D.F., Micheau O., Doucey M.A., Tschopp J., and Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18 (2003) 655-664
17. Ordureau A., Smith H., Windheim M., Peggie M., Carrick E., Morrice N., and Cohen P. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 409 (2008) 43-52
18. Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., and Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21 (2003) 921-926
19. Pickart C.M., and Raasi S. Controlled synthesis of polyubiquitin chains. Methods Enzymol. 399 (2005) 21-36
20. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
21. Sidhu S.S., Lowman H.B., Cunningham B.C., and Wells J.A. Phage display for selection of novel binding peptides. Methods Enzymol. 328 (2000) 333-363
22. Spence J., Sadis S., Haas A.L., and Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 15 (1995) 1265-1273
23. Thomas J.A., Allen J.L., Tsen M., Dubnicoff T., Danao J., Liao X.C., Cao Z., and Wasserman S.A. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163 (1999) 978-984
24. Varadan R., Walker O., Pickart C., and Fushman D. Structural properties of polyubiquitin chains in solution. J. Mol. Biol. 324 (2002) 637-647
25. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
26. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 (2004) 694-699
27. Windheim M., Stafford M., Peggie M., and Cohen P. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. Mol. Cell. Biol. 28 (2008) 1783-1791
28. Xiao H., Qian W., Staschke K., Jiang Z., Qian Y., Cui G., Deng L., Chen Z.J., Gilmour R., and Li X. Pellino 3b negatively regulates IL-1-indcued TAK1-dependent NF kappaB activation. J. Biol. Chem. 283 (2008) 14654-14664
29. Yamin T.T., and Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272 (1997) 21540-21547